These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35948929)

  • 1. CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection.
    Schmidt JK; Reynolds MR; Golos TG; Slukvin II
    Retrovirology; 2022 Aug; 19(1):17. PubMed ID: 35948929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated genome editing in nonhuman primates.
    Kang Y; Chu C; Wang F; Niu Y
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31636095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
    Xu L; Yang H; Gao Y; Chen Z; Xie L; Liu Y; Liu Y; Wang X; Li H; Lai W; He Y; Yao A; Ma L; Shao Y; Zhang B; Wang C; Chen H; Deng H
    Mol Ther; 2017 Aug; 25(8):1782-1789. PubMed ID: 28527722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus.
    D'Souza SS; Kumar A; Weinfurter J; Park MA; Maufort J; Tao L; Kang H; Dettle ST; Golos T; Thomson JA; Reynolds MR; Slukvin I
    Stem Cell Reports; 2022 Apr; 17(4):953-963. PubMed ID: 35364011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
    Au TY; Arudkumar J; Assavarittirong C; Benjamin S
    Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos.
    Schmidt JK; Strelchenko N; Park MA; Kim YH; Mean KD; Schotzko ML; Kang HJ; Golos TG; Slukvin II
    Sci Rep; 2020 Oct; 10(1):18457. PubMed ID: 33116147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Efficiency for Biallelic Mutations of the
    Lin D; Scheller SH; Robinson MM; Izadpanah R; Alt EU; Braun SE
    CRISPR J; 2021 Feb; 4(1):92-103. PubMed ID: 33616448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
    Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 system and its applications in human hematopoietic cells.
    Hu X
    Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates.
    Humbert O; Radtke S; Samuelson C; Carrillo RR; Perez AM; Reddy SS; Lux C; Pattabhi S; Schefter LE; Negre O; Lee CM; Bao G; Adair JE; Peterson CW; Rawlings DJ; Scharenberg AM; Kiem HP
    Sci Transl Med; 2019 Jul; 11(503):. PubMed ID: 31366580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.
    Smith LM; Ladner JT; Hodara VL; Parodi LM; Harris RA; Callery JE; Lai Z; Zou Y; Raveedran M; Rogers J; Giavedoni LD
    J Virol; 2021 Nov; 95(23):e0088221. PubMed ID: 34549979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
    Khan A; Paneerselvam N; Lawson BR
    Clin Immunol; 2023 Oct; 255():109741. PubMed ID: 37611838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies.
    Liu S; Wang Q; Yu X; Li Y; Guo Y; Liu Z; Sun F; Hou W; Li C; Wu L; Guo D; Chen S
    Sci Rep; 2018 Jun; 8(1):8573. PubMed ID: 29872154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy.
    Wang S; Ren S; Bai R; Xiao P; Zhou Q; Zhou Y; Zhou Z; Niu Y; Ji W; Chen Y
    J Biol Chem; 2018 Jul; 293(30):11654-11658. PubMed ID: 29941452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental progress of CRISPR/Cas9 and its therapeutic applications for HIV-1 infection.
    Deng Q; Chen Z; Shi L; Lin H
    Rev Med Virol; 2018 Sep; 28(5):e1998. PubMed ID: 30024073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Xu M
    Cell Biosci; 2020; 10():48. PubMed ID: 32257106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
    Dever DP; Porteus MH
    Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.